Bliss GVS Pharma Ltd - Stock Price

As on25 Sep 2020
  • NSE : BLISSGVS
  • BSE : 506197
  • ISIN CODE : INE416D01022
  • Industry : Pharmaceuticals & Drugs
  • House : Private
Bliss GVS Pharma Ltd is not traded on BSE/NSE
NSE
149.35
+1.77 %+2.6
BSE
150.70
+2.27 %+3.35

Balance Sheet

Parameter MAR 20  MAR 19  YoY %Change
EQUITY AND LIABILITIESNANANA
Share Capital103.15103.150.00
    Equity - Authorised150.00150.000.00
    Equity - Issued103.15103.150.00
    Equity Paid Up103.15103.150.00
    Equity Shares Forfeited0.000.000.00
    Adjustments to Equity0.000.000.00
    Preference Capital Paid Up0.000.000.00
    Face Value1.001.000.00
Share Warrants & Outstandings0.000.000.00
Total Reserves7252.986356.8414.10
    Securities Premium147.57147.570.00
    Capital Reserves0.000.000.00
    Profit & Loss Account Balance6733.715877.6614.56
    General Reserves454.15454.150.00
    Other Reserves-82.45-122.5432.72
Reserve excluding Revaluation Reserve7252.986356.8414.10
Revaluation reserve0.000.000.00
Shareholder's Funds7356.136459.9913.87
Minority Interest147.59138.646.45
Long-Term Borrowings0.000.000.00
Secured Loans372.39325.3814.45
    Non Convertible Debentures0.000.000.00
    Converible Debentures & Bonds0.000.000.00
    Packing Credit - Bank0.000.000.00
    Inter Corporate & Security Deposit0.000.000.00
    Term Loans - Banks381.07375.471.49
    Term Loans - Institutions0.000.000.00
    Other Secured-8.68-50.1082.67
Unsecured Loans0.000.000.00
    Fixed Deposits - Public0.000.000.00
    Loans and advances from subsidiaries0.000.000.00
    Inter Corporate Deposits (Unsecured)0.000.000.00
    Foreign Currency Convertible Notes0.000.000.00
    Long Term Loan in Foreign Currency0.000.000.00
    Loans - Banks0.000.000.00
    Loans - Govt.0.000.000.00
    Loans - Others0.000.000.00
    Other Unsecured Loan0.000.000.00
Deferred Tax Assets / Liabilities35.5535.73-0.51
    Deferred Tax Assets35.729.63270.82
    Deferred Tax Liability71.2645.3657.10
Other Long Term Liabilities32.351.282430.91
Long Term Trade Payables0.000.000.00
Long Term Provisions24.3917.5139.35
Total Non-Current Liabilities464.67379.8922.32
Current LiabilitiesNANANA
Trade Payables941.54788.8419.36
    Sundry Creditors941.54788.8419.36
    Acceptances0.000.000.00
    Due to Subsidiaries- Trade Payables0.000.000.00
Other Current Liabilities546.33502.368.75
    Bank Overdraft / Short term credit0.000.000.00
    Advances received from customers232.22217.066.98
    Interest Accrued But Not Due3.694.45-17.20
    Share Application Money0.000.000.00
    Current maturity of Debentures & Bonds0.000.000.00
    Current maturity - Others0.000.000.00
    Other Liabilities310.43280.8510.53
Short Term Borrowings663.85642.963.25
    Secured ST Loans repayable on Demands663.85631.085.19
    Working Capital Loans- Sec309.53290.866.42
    Buyers Credits - Unsec0.000.000.00
    Commercial Borrowings- Unsec0.000.000.00
    Other Unsecured Loans-309.53-278.98-10.95
Short Term Provisions170.12136.1025.00
    Proposed Equity Dividend0.000.000.00
    Provision for Corporate Dividend Tax0.000.000.00
    Provision for Tax98.61110.58-10.83
    Provision for post retirement benefits0.000.000.00
    Preference Dividend0.000.000.00
    Other Provisions71.5225.52180.20
Total Current Liabilities2321.842070.2512.15
Total Liabilities10290.249048.7713.72
ASSETSNANANA
Gross Block2760.661698.9162.50
Less: Accumulated Depreciation350.97249.2340.82
Less: Impairment of Assets0.000.000.00
Net Block2409.701449.6866.22
Lease Adjustment A/c0.000.000.00
Capital Work in Progress0.00467.44-100.00
Non Current Investments7.167.17-0.25
Long Term Investment7.167.17-0.25
    Quoted0.000.000.00
    Unquoted7.167.17-0.25
Long Term Loans & Advances131.53186.25-29.38
Other Non Current Assets12.363.31273.22
Total Non-Current Assets2560.742113.8621.14
Current Assets Loans & AdvancesNANANA
Currents Investments0.000.000.00
    Quoted0.000.000.00
    Unquoted0.000.000.00
Inventories741.38773.67-4.17
    Raw Materials366.28363.090.88
    Work-in Progress50.9848.235.69
    Finished Goods214.87231.29-7.10
    Packing Materials114.94113.671.11
    Stores  and Spare19.0612.7948.96
    Other Inventory-24.744.60-638.04
Sundry Debtors5479.124607.3018.92
    Debtors more than Six months38.0415.00153.60
    Debtors Others5504.434615.9219.25
Cash and Bank1033.191066.28-3.10
    Cash in hand0.591.62-63.70
    Balances at Bank1032.611064.66-3.01
    Other cash and bank balances0.000.000.00
Other Current Assets168.66262.12-35.66
    Interest accrued on Investments25.6752.04-50.66
    Interest accrued on Debentures0.000.000.00
    Deposits with Government0.000.000.00
    Interest accrued and or due on loans0.000.000.00
    Prepaid Expenses23.678.43180.65
    Other current_assets119.31201.65-40.83
Short Term Loans and Advances307.15225.5436.18
    Advances recoverable in cash or in kind197.38136.5644.54
    Advance income tax and TDS5.222.04155.66
    Amounts due from directors0.000.000.00
    Due From Subsidiaries0.000.000.00
    Inter corporate deposits0.000.000.00
    Corporate Deposits0.000.000.00
    Other Loans & Advances104.5586.9520.24
Total Current Assets7729.496934.9111.46
Net Current Assets (Including Current Investments)5407.654864.6611.16
Miscellaneous Expenses not written off0.000.000.00
Total Assets10290.249048.7713.72
Contingent Liabilities138.4920.86563.82
Total Debt1209.631019.4018.66
Book Value71.3262.6313.87
Adjusted Book Value71.3262.6313.87

About Bliss GVS Pharma Ltd.

Bliss GVS Pharma Ltd. was incorporated in the year 1984. Its today's share price is 150.7. Its current market capitalisation stands at Rs 1554.42 Cr. In the latest quarter, company has reported Gross Sales of Rs. 6893.09 Cr and Total Income of Rs.7264.28 Cr. The company's management includes Shruti Vishal Rao, Vibha Gagan Sharma, Shilpa Bhatia, Santosh Parab, S N Kamath, S R Vaidya.

It is listed on the BSE with a BSE Code of 506197 , NSE with an NSE Symbol of BLISSGVS and ISIN of INE416D01022. It's Registered office is at 102, Hyde Park,Saki Vihar Road,Andheri (East) Mumbai-400072, Maharashtra. Their Registrars are ACC Ltd. It's auditors are BK Khare & Co, Kalyaniwalla & Mistry LLP

Latest News

close